Hitoshi Kawazoe
Ehime University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hitoshi Kawazoe.
Journal of Clinical Pharmacy and Therapeutics | 2009
Hiroaki Tanaka; M. Kaji; Kazuko Higuchi; Naoki Shinohara; M. Norimatsu; Hitoshi Kawazoe; M. Ninomiya; Noriyasu Fukuoka; N. Ishii; J. Fujita; Akinobu Okabe; Hitoshi Houchi
Background and objective: Pertussis developed in Kagawa University Medical School and University Hospital in May 2007. To control the outbreak and prevent the infection of hospital inpatients, the Infection Control Team (ICT) carried out the prophylactic administration of erythromycin (EM) to hospital staff (1566 staff) who might be exposed to Bordetella pertussis.
Biological & Pharmaceutical Bulletin | 2017
Kenshi Takechi; Yurika Yoshioka; Hitoshi Kawazoe; Mamoru Tanaka; Shingo Takatori; Miwako Kobayashi; Ichiro Matsuoka; Hiroaki Yanagawa; Yoshito Zamami; Masaki Imanishi; Keisuke Ishizawa; Akihiro Tanaka; Hiroaki Araki
Treatment with antipsychotic drugs has been associated with hyperprolactinemia. The same antipsychotic drugs have also been associated with side effects such as menstruation disorders. The aim of this study was to evaluate the prevalence of hyperprolactinemia and menstruation disorders in women undergoing antipsychotic treatment. We performed a retrospective chart review study of psychiatric patients who underwent laboratory testing for serum prolactin (PRL) level between March 2011 and March 2015 in Ehime University Hospital. Patients presenting with and without menstruation disorders were evaluated to determine if they presented concomitant hyperprolactinemia. Patients with menstrual disorders had a significant increase in serum PRL level with a mean of approximately 90 ng/mL. Those with menstrual disorders presented increased PRL levels by 2-fold that of patients without menstrual disorder. However, there was no significant difference in the equivalent dose of chlorpromazine between these two groups. Additionally, about 70% of patients with menstrual disorders received risperidone treatment. The receiver operating characteristic curve showed that the optimal cutoff point of serum PRL level associated with the development of menstrual disorders was 60 ng/mL. Based on these results, we concluded that patients with menstrual disorders presented increased serum PRL, and that most of them underwent treatment with risperidone.
Biological & Pharmaceutical Bulletin | 2006
Hitoshi Kawazoe; Yoshiharu Takiguchi; Hiroaki Tanaka; Noriyasu Fukuoka; Hiroaki Ohnishi; Toshihiko Ishida; Hitoshi Houchi
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2006
Hitoshi Kawazoe; Tomomi Kubo; Naomi Iihara; Chiaki Doi; Makiko Okujyoh; Noriyasu Fukuoka; Satoshi Fujimoto; Nobuhiro Kanaji; Shuji Bandoh; Toshihiko Ishida; Yoshiharu Takiguchi; Hitoshi Houchi
Gan to kagaku ryoho. Cancer & chemotherapy | 2010
Hitoshi Kawazoe; Sugishita H; Watanabe S; Tanaka A; Morioka J; Suemaru K; Watanabe Y; Kawachi K; Araki H
Japanese Journal of Pharmaceutical Health Care and Sciences | 2014
Hitoshi Kawazoe; Masaki Ueno; Satomi Sumikawa; Mamoru Tanaka; Akihiro Tanaka; Hiroaki Araki
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2007
Hitoshi Kawazoe; Yoshiharu Takiguchi; Hiroaki Tanaka; Chiaki Doi; Noriyasu Fukuoka; Nobuhiro Kanaji; Shuji Bandoh; Toshihiko Ishida; Hitoshi Houchi
Gan to kagaku ryoho. Cancer & chemotherapy | 2013
Miyajima R; Hitoshi Kawazoe; Tsuneoka K; Fujiwara M; Kojima Y; Yoshihiro Yakushijin
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2007
Hitoshi Kawazoe; Yoshiharu Takiguchi; Hiroaki Tanaka; Masaki Ninomiya; Noriyasu Fukuoka; Hiroaki Ohnishi; Toshihiko Ishida; Hitoshi Houchi
International Journal of Clinical Pharmacy | 2017
Hitoshi Kawazoe; Satomi Sumikawa; Kana Nakauchi; Yoshihiro Yakushijin; Yuji Yamamoto; Yuji Watanabe; Akihiro Tanaka; Hiroaki Araki